In April 2026, the U.S. Department of Justice (DOJ) and Drug Enforcement Administration (DEA) announced a significant shift in federal cannabis policy. Effective immediately, the following categories of marijuana have been rescheduled from Schedule I to Schedule III under the Controlled Substances Act (CSA): (i) U.S. Food and Drug Administration (FDA)-approved drug products that contain marijuana; and (ii) marijuana in any form covered by a state medical marijuana license.
On May 7, 2026, Ohio Attorney General (AG) Dave Yost announced his resignation after having served in the role since 2019.
Artificial intelligence is everywhere now: in your contracts, your research workflows, your customer service queue. And if your company is using it without thinking carefully about trade secret exposure, you may be quietly dismantling critical protections your company has spent years building.
The Commonwealth of Pennsylvania has alleged an AI company’s chatbot engaged in the unauthorized practice of medicine. This lawsuit not only signals how state regulators are potentially evaluating AI-driven health interactions, but it could also have sweeping implications for health IT companies and their operational risk.
In this joint episode of Payments Pros and The Consumer Finance Podcast, guest host Taylor Gess is joined by Stefanie Jackman to discuss amended debt collection regulations and restrictions for creditors, including tight communication limits and enhanced validation requirements. The conversation dives into the rise of coerced debt statutes, shortcomings of traditional identity theft frameworks, and how creditors should adjust training, intake, and escalation protocols to avoid reputational and legal risk. The discussion also explores state medical debt reporting bans, the preemption challenges, and cautious furnishing in the FCRA landscape.
Ashley L. Taylor, Jr., co-leader of Troutman Pepper Locke’s State Attorneys General Practice Group, was quoted in the May 5, 2026, Law360 article, “High Court Clarity On Subpoenas Creates Murky Path For AGs.”
In this episode of Regulatory Oversight, host Ashley Taylor continues the multipart series on artificial intelligence with colleagues Ghillaine Reid, David Stauss, and Matt Berns for a practical look at how states are actually regulating AI in 2025–26. Framed through a consumer protection lens, the discussion moves beyond theoretical federal proposals to real bills and regulations moving through state legislatures today.
The FTC has announced a “Made in the USA” enforcement sweep, bringing three federal actions and issuing two closing letters, following its July 2025 warning letters to companies about “Made in USA” compliance and President Donald Trump’s March 13, 2026, executive order “Ensuring Truthful Advertising of Products Claiming to be Made in America,” directing the agency to prioritize U.S.-origin claim enforcement.
This article was originally published in Dow Jones Risk Journal on May 4, 2026.
Prediction markets allow users to trade event contracts on real-world events, such as election outcomes, sporting events and even the highest temperature in New York City today. Seemingly overnight, they have achieved mainstream prominence. Since 2025, Kalshi’s user base alone has grown from approximately 600,000 to more than 5,000,000.
On April 27, 2026, Washington’s attorney general (AG) filed suit against Albertsons and Safeway, accusing the grocery chains of inflating prices before “buy one, get one free” (BOGO) promotions — allegedly pocketing nearly $20 million from unsuspecting shoppers. The complaint, filed in King County Superior Court, alleges roughly 3.1 million transactions were affected between October 2019 and May 2024.